Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
1999 2
2002 1
2007 1
2008 1
2012 1
2014 1
2019 2
2020 5
2021 3
2022 5
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB; PULSAR Trial Investigators. Humbert M, et al. N Engl J Med. 2021 Apr 1;384(13):1204-1215. doi: 10.1056/NEJMoa2024277. N Engl J Med. 2021. PMID: 33789009 Clinical Trial.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034 Free PMC article.
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases.
Pulito-Cueto V, Genre F, López-Mejías R, Mora-Cuesta VM, Iturbe-Fernández D, Portilla V, Sebastián Mora-Gil M, Ocejo-Vinyals JG, Gualillo O, Blanco R, Corrales A, Ferraz-Amaro I, Castañeda S, Cifrián Martínez JM, Atienza-Mateo B, Remuzgo-Martínez S, González-Gay MÁ. Pulito-Cueto V, et al. Among authors: cifrian martinez jm. Int J Mol Sci. 2023 Jan 9;24(2):1275. doi: 10.3390/ijms24021275. Int J Mol Sci. 2023. PMID: 36674789 Free PMC article.
Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study.
Mora Cuesta VM, Iturbe Fernández D, Aguado Ibáñez S, Anguera de Francisco G, Margallo Iribarnegaray J, Carrillo Hernández-Rubio J, Reig Mezquida JP, Pérez Luz V, Laporta Hernández R, de Pablo Gafas A, Solé Jover A, Cifrián Martínez JM. Mora Cuesta VM, et al. Among authors: cifrian martinez jm. Respirology. 2022 Dec;27(12):1054-1063. doi: 10.1111/resp.14352. Epub 2022 Aug 28. Respirology. 2022. PMID: 36053911
Lung transplantation for emphysema: only emphysema or something else?
Mora-Cuesta VM, Sánchez-Moreno L, Iturbe-Fernández D, Pérez-Barquín E, Tello-Mena S, Alonso-Lecue P, Izquierdo-Cuervo S, Naranjo-Gozalo S, Cifrián-Martínez JM, Gómez-Román JJ. Mora-Cuesta VM, et al. Among authors: cifrian martinez jm. J Thorac Dis. 2023 Dec 30;15(12):6741-6751. doi: 10.21037/jtd-23-1160. Epub 2023 Dec 15. J Thorac Dis. 2023. PMID: 38249891 Free PMC article.
Strategy for the Elimination of Hepatitis C in Cantabria.
Crespo J, Tejerina Puente A, Cuadrado A, Llerena S, Cabezas J; Grupo de Trabajo para la Eliminación de la Hepatitis C en Cantabria. Crespo J, et al. Rev Esp Enferm Dig. 2020 Jul;112(7):565-570. doi: 10.17235/reed.2020.7108/2020. Rev Esp Enferm Dig. 2020. PMID: 32543873 Free article.
34 results